Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
03/2009
03/31/2009US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor
03/31/2009CA2292549C Use of colchinol derivatives as vascular damaging agents
03/26/2009WO2009038879A2 Stem cell differentiating agents and uses therefor
03/26/2009WO2009038204A1 Novel long-chain fatty acid derivative compound and g-protein-coupled receptor agonist containing the compound as active ingredient
03/26/2009WO2009037497A1 Process for preparing sulphonamides
03/26/2009WO2009037416A1 Process for preparing sulphonamides
03/26/2009US20090082457 (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide; MEK kinase (mitogen-activated ERK-activating kinases, MAP kinase kinase); cancer, tumors, autoimmune disorders, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis
03/26/2009US20090082456 Soluble epoxide hydrolase inhibitors
03/25/2009EP2039681A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same
03/25/2009CN100471834C Process for preparing fluorochemical monoisocyanates
03/19/2009WO2009035928A1 Soluble epoxide hydrolase inhibitors
03/19/2009WO2009034432A2 Novel compounds active as muscarinic receptor antagonists
03/19/2009WO2008131946A3 Substituted amide derivatives
03/19/2009US20090076178 Cross-Linkable Bi-Sulphonyl Derivatives And Their Uses For Preparing Ion-Exchanging Membranes
03/19/2009US20090076152 Novel Compounds Active as Muscarinic Receptor Antagonists
03/19/2009US20090076103 Stem cell differentiating agents and uses therefor
03/19/2009US20090074746 Compounds to treat alzheimer's disease
03/19/2009CA2699463A1 Novel compounds active as muscarinic receptor antagonists
03/18/2009EP2036886A1 Association between an anti-atherothrombotic and an angiotensin conversion enzyme inhibitor
03/18/2009EP1805129B1 (biphenyl) carboxylic acids and derivatives thereof
03/18/2009EP1689380A4 Method for treating adamts-5-associated disease
03/18/2009EP1615629B1 Peptide deformylase inhibitors
03/18/2009CN100469592C Thermosensitive recording materials
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504431 Sulfonyl amide inhibitors of calcium channel function
03/17/2009US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/17/2009US7504413 N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
03/17/2009CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
03/17/2009CA2406363C A container assembly for fertilization and culture and embryo transfer and method of fertilization and culture employing such a container
03/12/2009US20090069302 Chemical compounds
03/12/2009US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt
03/12/2009DE102007042154A1 Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel Arylsulfonylaminomethyphosphonsäure derivatives, their preparation and their use as medicaments
03/11/2009EP1940782B1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors
03/11/2009EP0976722B1 Benzamidine derivatives
03/11/2009CN101384579A Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
03/11/2009CN101384540A Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
03/11/2009CN101381332A Ibutilide fumarate synthetic process
03/11/2009CN100467447C Thioamide compound or its salt and cytokine production inhibitor containing the same
03/11/2009CA2638354A1 Association of an anti-atherothrombotic and an angiotensin converting enzyme inhibitor
03/10/2009US7501538 Erythropoietin receptor activators; inducing red blood cell production and maturation
03/10/2009CA2345069C 2-phenylpyran-4-one derivatives
03/05/2009WO2008152334A3 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090060838 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
03/05/2009DE102007041965A1 New N-arylbenzyl-N'-arylsulfonyl-1,2-diphenyl-1,2-ethanediamine ligands useful for preparing rhodium complex catalysts for asymmetric hydrogenation
03/05/2009DE102007041232A1 Washing and cleaning composition for cleaning of textiles and hard surfaces and for removal of burned or persistent dirt, comprises urea derivatives, which is sulfonyl urea
03/04/2009EP2029526A1 Lysine related derivatives as hiv aspartyl protease inhibitors
03/04/2009EP0869974B1 Compounds with growth hormone releasing properties
03/04/2009CN101379070A Oxonium and sulfonium salts
03/03/2009US7498436 Substituted hydroxyethylamines
03/03/2009US7498358 Human ADAM-10 inhibitors
02/2009
02/26/2009US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
02/26/2009US20090054439 Sulfonamide derivatives, preparation and therapeutic application thereof
02/25/2009EP1856031B1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
02/25/2009EP1143965B1 Carbocyclic potassium channel inhibitors
02/25/2009CN101374804A Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
02/19/2009WO2009022721A1 Tricyclic amide compound
02/19/2009WO2009022681A1 Positive resist composition, pattern forming method using the composition, and compound used in the composition
02/19/2009WO2009021945A1 New compounds
02/19/2009WO2009021944A1 New compounds
02/19/2009WO2008154414A3 Water- and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties
02/19/2009WO2008152333A3 Novel derivatives of 3-phenyl propanoic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions
02/19/2009US20090048337 Modulation of anxiety through blockade of anandamide hydrolysis
02/19/2009US20090048224 Compounds and methods of use
02/19/2009CA2696302A1 New compounds
02/19/2009CA2696261A1 New compounds
02/19/2009CA2695977A1 Tricyclic amide compound
02/18/2009EP2025673A1 Arylsulfonamides with analgetic activity
02/18/2009EP2025668A1 Arylsulfonamides with analgetic activity
02/18/2009EP2024329A2 (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them
02/18/2009EP2024327A1 Benzoyl-substituted alanines
02/18/2009EP2024326A2 Methods for preparing glutamic acid derivatives and intermediates thereof
02/18/2009EP1732903B1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
02/18/2009EP1274353B1 A container assembly for fertilization and culture
02/18/2009EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease
02/17/2009US7491748 e.g. (1) 3-(2-((naphthalen-1-ylmethyl)carbamoyl)-4-(2-methylphenoxymethyl)phenyl)propanoic acid; prostaglandin (PGE2) receptor ligand; analgesic, anticarcinogenic agent, antiallergen; neurodegenerative diseases
02/17/2009US7491741 Diaminopropionic acid derivatives
02/17/2009US7491739 TNF-α production inhibitors
02/17/2009CA2157143C Alkylbenzoylguanidine derivatives
02/12/2009US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
02/12/2009US20090042996 reduced fluorine content increases cost efficiency
02/12/2009US20090042973 Inhibitors of aspartyl protease
02/12/2009US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors
02/12/2009CA2696247A1 Preparation of synthetic nucleosides via .pi.-allyl transition metal complex formation
02/10/2009CA2189044C Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
02/05/2009WO2009016083A1 Degradation accelerator for polymers and polymer article comprising it
02/05/2009DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases
02/05/2009CA2693390A1 Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
02/04/2009EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
02/04/2009EP1565422B1 Vitamin d receptor modulators
02/04/2009CN101360706A (R)-arylalkylamino derivatives and pharmaceutical compositions containing them
02/04/2009CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
01/2009
01/29/2009WO2009015028A1 Substituted cyclohexenes
01/29/2009WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1
01/29/2009WO2009012954A1 Novel estrogen receptor ligands
01/29/2009WO2008049595A9 Trypsin-like serine protease inhibitors, and their preparation and use
01/29/2009US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
01/29/2009US20090029903 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors
01/28/2009CN101356149A Indene derivatives, their preparation and use as medicaments
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 177